Source: Pharmacological research. Unidade: FM
Subjects: TRANSFERASES, CAMUNDONGOS, CHOQUE SÉPTICO, ESTRESSE OXIDATIVO, LIGADURA, PUNÇÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AHMAD, Akbar et al. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, v. 145, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2019.104263. Acesso em: 08 nov. 2024.APA
Ahmad, A., Vieira, J. de C., Mello, A. H. de, Lima, T. M. de, Ariga, S. K., Barbeiro, D. F., et al. (2019). The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, 145. doi:10.1016/j.phrs.2019.104263NLM
Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263Vancouver
Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263
